AI Based Real Time Detection of Endometriosis Lesions

Launched by UNIVERSITY HOSPITAL TUEBINGEN · Mar 6, 2025

Keywords

ClinConnect Summary

This clinical trial is examining a new way to help doctors detect endometriosis, a condition where tissue similar to the lining of the uterus grows outside of it. Researchers are developing an artificial intelligence (AI) tool that can automatically identify endometriosis lesions using images and videos taken during surgery. This AI-based approach aims to improve the accuracy and speed of diagnosis, which could lead to better treatment for patients.

To participate in this trial, women aged 18 and older who are scheduled to have surgery for endometriosis can apply. Participants will be asked to give their written consent, meaning they agree to take part after understanding what the study involves. It’s important to note that patients should be able to follow instructions and understand the trial's purpose. Those with other cancers or who cannot give consent will not be eligible. If you qualify and choose to participate, you can expect to help in the development of new technology that could make diagnosing endometriosis easier for future patients.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years
• • Written consent after explanation
• • Indication for surgical treatment of endometriosis
• Exclusion Criteria:
• • Expected lack of patient compliance or inability of the patient to understand the purpose of the clinical trial
• • Absence of patient consent
• • Malignancies